Xianzhi Meng
Harbin Medical University(CN)Q Therapeutics (United States)(US)First Affiliated Hospital of Harbin Medical University(CN)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Cancer-related Molecular Pathways, Cholangiocarcinoma and Gallbladder Cancer Studies, Pancreatitis Pathology and Treatment, RNA modifications and cancer
Most-Cited Works
- → Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma(2013)293 cited
- → Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis(2014)129 cited
- → PTEN‐ and p53‐mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice(2010)87 cited
- → RETRACTED ARTICLE: KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling(2018)86 cited
- → The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway(2014)82 cited
- → Anti-cancer activity of DHA on gastric cancer—an in vitro and in vivo study(2013)77 cited